Olive Leaf Extract in Handball Players

January 22, 2026 updated by: Büşra Demirer, Karabuk University

Effects of Short-Term Olive Leaf Extract Supplementation in Elite Male Handball Players

Olive leaf extract (OLE) is a natural supplement rich in phenolic compounds, especially oleuropein, which has antioxidant properties that may support recovery after physical exercise. While OLE has been studied for various health-related effects, its potential impact on exercise recovery and performance in elite athletes remains unclear.

This randomized, double-blind, placebo-controlled study was designed to evaluate the effects of four weeks of OLE supplementation on physical performance, sleep quality, and post-exercise muscle soreness in elite male handball players aged 18 to 25 years. Participants were randomly assigned to receive either a daily OLE supplement (500 mg, standardized to 25% oleuropein) or a placebo for four weeks. Physical performance, sleep quality, and muscle soreness were assessed at baseline, during the intervention, and at the end of the study period. Muscle soreness was additionally evaluated at 12 and 24 hours following exercise sessions.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central
      • Karabük, Central, Turkey (Türkiye), 78050
        • Karabuk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male elite handball players aged 18 years or older
  • Free from any diagnosed chronic disease, as determined by medical history
  • Not following a calorie-restricted diet within the previous six months
  • No use of nutritional supplements within the previous six months

Exclusion Criteria:

  • Age under 18 years
  • Smoking or alcohol consumption
  • Presence of any diagnosed chronic disease
  • Adherence to a regular calorie-restricted diet within the previous six months
  • Use of nutritional supplements during the previous six months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study group
olive leaf extract supplemented
OLE supplement (500 mg, standardized to 25% oleuropein)
Placebo Comparator: Control group
placebo capsule supplemented
Sucrose capsules with the same color, scent, and size as OLE capsules.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Soreness
Time Frame: Baseline, After intervention (two week later), After intervention (fourt week later)
The severity of muscle soreness will be assessed using the Visual Analog Scale (VAS). Patients choose the appropriate score between 0 and 10. Higher scores indicate higher muscle soreness levels.
Baseline, After intervention (two week later), After intervention (fourt week later)
Squat jump height
Time Frame: Performance outcomes were assessed at baseline, week 2, and week 4 of the intervention period.
Lower-body explosive performance was assessed using the squat jump test. Jump height was measured in centimeters (cm) with higher values indicating better explosive performance.
Performance outcomes were assessed at baseline, week 2, and week 4 of the intervention period.
Peak anaerobic power
Time Frame: baseline, week 2, and week 4.
Peak anaerobic power was assessed using the Wingate anaerobic test. Peak power output was recorded in watts (W) during the 30-second maximal cycling test. Higher values indicate greater anaerobic power.
baseline, week 2, and week 4.
Countermovement jump height
Time Frame: Assessments were conducted at baseline, week 2, and week 4. Higher values indicate better explosive performance.
Lower-body explosive performance was assessed using the countermovement jump test. Jump height was measured in centimeters (cm) with higher values indicating better explosive performance.
Assessments were conducted at baseline, week 2, and week 4. Higher values indicate better explosive performance.
Mean anaerobic power
Time Frame: Baseline, week 2, and week 4
Mean anaerobic power was assessed using the Wingate anaerobic test. Mean power output was calculated as the average power produced over the 30-second test and recorded in watts (W). Higher values indicate better anaerobic capacity.
Baseline, week 2, and week 4
Fatigue index
Time Frame: Baseline, week 2, and week 4
Fatigue index was assessed using the Wingate anaerobic test and calculated as the percentage decline in power output from peak to minimum power during the 30-second test. Higher values indicate greater fatigue.
Baseline, week 2, and week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality
Time Frame: Total PSQI scores were recorded at baseline, week 2, and week 4 to evaluate changes in perceived sleep quality during the supplementation period.
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) total score. The PSQI is a validated self-reported questionnaire consisting of 19 items, yielding a global score ranging from 0 to 21, with higher scores indicating poorer sleep quality.
Total PSQI scores were recorded at baseline, week 2, and week 4 to evaluate changes in perceived sleep quality during the supplementation period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

January 15, 2025

Study Completion (Actual)

February 1, 2025

Study Registration Dates

First Submitted

January 15, 2026

First Submitted That Met QC Criteria

January 22, 2026

First Posted (Actual)

January 27, 2026

Study Record Updates

Last Update Posted (Actual)

January 27, 2026

Last Update Submitted That Met QC Criteria

January 22, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • handball players

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Handball Players

Clinical Trials on Olive leaf extract

Subscribe